QuanterLab vs Doxt Stock

A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.

QuanterLab compared with Doxt Stock
Detail	QuanterLab	Doxt Stock
What it does	Quantitative research platform for building and testing systematic trading strategies with point-in-time backtests and walk-forward validation	A judgment you can verify
Stage	Startup	Not given
Founded	2025	Not given
Based in	DE	Not given
Pricing model	Freemium	Free
Pricing	Starter €7.99/month, Practitioner €19.50/month (regularly €39), Research €34.50/month (regularly €69). All prices include VAT. Every new account gets 30 days of Practitioner free with no card required.	Not given
Key features	Visual strategy builder with circuit diagram interface Point-in-time backtesting over 20 years of history Walk-forward validation and robustness testing Indicator strategies with mean reversion and momentum Stochastic methods including Kalman filter and Ornstein-Uhlenbeck models Factor model and portfolio construction tools Paper trading with daily marked prices Python code export for backtests and strategies Regime analysis and market regime detection	Public append-only ledger of all judgments Settlement against real market prices after 5 trading days Preregistered settlement thresholds of ±1.0% Hash-chained records at database level Hit rate and coverage metrics Baseline comparisons: always-bullish, buy & hold, cash Simulated paper account with commissions and slippage Adjusted prices including splits and dividends Direction and confidence for each judgment
What makes it different	Point-in-time data discipline prevents look-ahead bias and ensures strategies see only information available on each date 113 published research articles and studies with reproducible methodology and full audit trail Circuit diagram interface makes strategy design accessible without requiring extensive coding Full Python export enables strategies to be deployed outside the platform	Every judgment published before settlement, including misses Settled by deterministic code, not curated Independently verifiable track record Transparent about what it is not: not financial advice, no money management
Community votes	0	0
DR (Domain Rating by Ahrefs)	5 +1 (up) since last check	8 +1 (up) since last check
Trust Flow (Majestic)	8	0
Citation Flow (Majestic)	28	4
Referring domains (Majestic)	22	2

4 details filled in for both companies.

More alternatives to QuanterLab More alternatives to Doxt Stock